A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1 |
| |
Authors: | Reindl Wolfgang Strebhardt Klaus Berg Thorsten |
| |
Affiliation: | a Department of Molecular Biology, Max Planck Institute of Biochemistry, Munich Center for Integrated Protein Science (CIPSM), Am Klopferspitz 18, 82152 Martinsried, Germany b Department of Gynaecology and Obstetrics, Johann Wolfgang Goethe-University, School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany |
| |
Abstract: | The serine/threonine kinase polo-like kinase 1 (Plk1) is critically involved in multiple mitotic processes and has been established as an adverse prognostic marker for tumor patients. Plk1 localizes to its substrates and its intracellular anchoring sites via its polo-box domain (PBD), which is unique to the family of polo-like kinases. Therefore, inhibition of the Plk1 PBD has been suggested as an approach to the inhibition of Plk1 that circumvents specificity problems associated with the inhibition of the conserved adenosine triphosphate (ATP) binding pocket. Here we report on the development of a high-throughput assay based on fluorescence polarization that allows the discovery of small-molecule inhibitors of the Plk1 PBD. The assay is based on binding of the Plk1 PBD to a phosphothreonine-containing peptide comprising its optimal binding motif with a Kd of 26 ± 2 nM. It is stable with regard to dimethyl sulfoxide (DMSO) and time, and it has a Z′ value of 0.73 ± 0.06 in a 384-well format. |
| |
Keywords: | Plk1 PBD Fluorescence polarization Assay development High-throughput screening |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|